Notícia

FSS Alerts - Forensic and Scientific Services (Austrália)

A high-specificity test detects prior infection by Zika virus

Publicado em 05 abril 2018

A test that detects antibodies against Zika virus in samples of blood serum with high specificity – and hence a low risk of cross-reaction with related microorganisms such as dengue virus – is set to come on to the Brazilian market before 2018 is out.

The method was designed by Brazilian scientists. Technology firm Inovatech, with the support from the São Paulo Research Foundation – FAPESP through its Innovative Research in Small Business Program (PIPE), developed the test in collaboration with scientists at the University of São Paulo’s Biomedical Science Institute (ICB-USP) and at the Butantan Institute.

https://www.eurekalert.org/pub_releases/2018-03/fda-aht032818.php